Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arianna Montruccoli

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Brain Research Bulletin|September 27, 2005
Two new putative susceptibility loci for ADNFLERomina Combi, Luigi Ferini-Strambi, Arianna Montruccoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patientsAlberto Bottini, Daniele Generali, Maria Pia Brizzi, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Brain Research Bulletin|September 27, 2005
Two new putative susceptibility loci for ADNFLERomina Combi, Luigi Ferini-Strambi, Arianna Montruccoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patientsAlberto Bottini, Daniele Generali, Maria Pia Brizzi, et al.
Pageof 1